insights_auto
Why is MEOBF up १०.०७%?
Dive Deeperchevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
US$ १.५३
arrow_upward
+१०.०७%(+०.१४) 1D
अक्टोबर ९, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEOBF...
Open
US$ १.५३
High
US$ १.५३
Low
US$ १.५३
Mkt. cap
१.८१ अरब
Avg. vol.
३८७.००
Volume
०.००
52-wk high
US$ २.५९
52-wk low
US$ १.१४
Beta
१.६८
Shares outstanding
१.३० अरब
No. of employees
१०८
Open
US$ १.५३
High
US$ १.५३
Low
US$ १.५३
Mkt. cap
१.८१ अरब
Avg. vol.
३८७.००
Volume
०.००
52-wk high
US$ २.५९
52-wk low
US$ १.१४
Beta
१.६८
Shares outstanding
१.३० अरब
No. of employees
१०८
News stories
From web sources and news partners
Simply Wall Street
·
५ घण्टा पहिले
ASX Penny Stocks To Watch In October 2026
TipRanks
·
१९ घण्टा पहिले
Mesoblast Sets Details for 2026 Annual General Meeting
TipRanks
·
१९ घण्टा पहिले
Mesoblast Files Updated Corporate Governance Statement and ASX Appendix 4G
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd